Patents by Inventor Ian Frank

Ian Frank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11311578
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: April 26, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11304980
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 19, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220096555
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: December 11, 2021
    Publication date: March 31, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220088080
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 24, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220088081
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 24, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11266694
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: March 8, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220008470
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 13, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220000928
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220000926
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220000927
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220000929
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20210401889
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 30, 2021
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11179419
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: November 23, 2021
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11141438
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: October 12, 2021
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11123371
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after restimulation.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: September 21, 2021
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20210260121
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 26, 2021
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20210252063
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 19, 2021
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20210252062
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 19, 2021
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11058728
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: July 13, 2021
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11026974
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: June 8, 2021
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze